Understanding the effects of insulin therapy on mortality outcomes is vital for the clinical management and glycemic control of diabetes, especially for those with type 1 or advanced type 2 diabetes who require exogenous insulin replacement [21–23]. The gene discussed is INS; the disease is type 2 diabetes mellitus.